BMED
iShares Health Innovation Active ETF
📎 Investment Objective
The iShares Health Innovation Active ETF (BMED) seeks to provide long-term capital growth by investing in companies that are positioned to benefit from advancements in the healthcare and life sciences sectors.
Overview
ETF tracking iShares Health Innovation Active ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The iShares Health Innovation Active ETF (BMED) seeks to provide long-term capital growth by investing in companies that are positioned to benefit from advancements in the healthcare and life sciences sectors.
🎯 Investment Strategy
BMED is an actively managed fund that invests in a portfolio of global healthcare and biotechnology companies that the fund's portfolio managers believe are at the forefront of innovation. The fund aims to identify companies with strong growth potential driven by new products, services, and technologies that can transform the healthcare industry.
✨ Key Features
- Active management approach to identify promising healthcare innovators
- Global exposure to companies across the healthcare value chain
- Emphasis on disruptive technologies and emerging healthcare trends
- Potentially higher risk/return profile compared to passive healthcare funds
⚠️ Primary Risks
- Sector concentration risk as the fund is focused on the healthcare industry
- Potential for higher volatility due to the fund's active management and focus on innovative companies
- Currency risk for investors as the fund holds international securities
- Liquidity risk as the fund is relatively new and has limited assets under management
👤 Best For
BMED may be suitable for investors with a long-term investment horizon who are seeking exposure to the healthcare sector and are comfortable with the potentially higher risk and return profile of an actively managed fund focused on innovative companies. This ETF may be appropriate as a satellite holding within a diversified portfolio.